Latest Proprietary Technology News

EBR Systems has expanded its intellectual property holdings with four new patents, reinforcing its lead in wireless cardiac pacing technology, while facing a preliminary setback on a patent term extension application.

Swift TV Ltd has landed a significant purchase order from Chevron for 2,000 connected TV devices, marking a key milestone in its enterprise technology rollout tailored for the Oil and Gas sector.

Firebird Metals has achieved a significant technical milestone with its manganese iron phosphate precursor outperforming China industry benchmarks, setting the stage for commercial production at its Australian Demonstration Plant in 2026.

6K Additive, Inc. launches a fully underwritten A$48 million IPO on the ASX, aiming to scale its innovative scrap-based metal powder production for additive manufacturing. The capital raise supports a major capacity expansion backed by a US Department of Defense grant.

Vulcan Energy has awarded a €72 million EPCM contract to a Sedgman and HOCHTIEF joint venture for its Phase One Lionheart Project, aiming to produce 24,000 tonnes of lithium hydroxide annually to fuel half a million electric vehicles.

Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.

Audeara Limited has achieved a key regulatory milestone with NMPA certification in China, paving the way for commercial launch of its hearing personalisation technology through a leading e-commerce brand. This approval supports the company’s strategy to generate scalable licensing revenue in a rapidly growing market.

Straker Ltd reports a solid first half of FY26 with positive EBITDA and a renewed IBM partnership, despite a 15% revenue decline amid challenging market conditions.

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.